ABEO

Abeona TherapeuticsA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

ABEO vs peer average

90/100

ABEO vs. peer average (A vs. C)

Grade spread

B 2 · C 1 · D 4 · F 1

Graded peers loaded

Coverage

9 graded

100% of tracked

Peer overview

KRYS is the first available peer comparator.

Krystal Biotech is the strongest public operating comparator because VYJUVEK is an approved COL7A1-directed treatment for dystrophic epidermolysis bullosa. Its topical, redosable model differs materially from ZEVASKYN's one-time autologous cell-sheet procedure, so revenue scale, margins, treatment cadence, and valuation are not directly transferable.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerKRYSKrystal Biotech

ABEO

Abeona Therapeutics

KRYS

Krystal Biotech

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs KRYS

ABEO / KRYS

Grade Position

Above peers

ABEO vs. peer average (A vs. C)

90/100

Momentum

KRYS

Value

KRYS

Sentiment

ABEO

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs ABEO

KRYS

80/100

VCRE

Vicore Pharma Holding AB ADR

N/A

IMRX

Immuneering Corp Class A Common

80/100

SCTX

Scribe Therapeutics Inc Common

60/100

SABS

SAB Biotherapeutics Inc Common

40/100

KRYS is the first peer returned for this comparison set.